HealthTree Logo
search more_vert
close
person Sign In / Create Account
Essential Research for Myeloma Cures with Faith Davies, MBBCh, MRCP, MD, FRCPath, NYU Langone
Essential Research for Myeloma Cures with Faith Davies, MBBCh, MRCP, MD, FRCPath, NYU Langone image
HealthTree Podcast for Multiple Myeloma
event Aug 30, 2023 / 01:00PM EDT

Event Description

In this episode, Faith Davies, MBBCh, MRCP, MD, FRCPath of the NYU Langone will share how research works in multiple myeloma, the various stages in clinical trials, the most critical steps that move curative therapies forward, how barriers to a cure can be removed and how patient participation is essential to the entire process. 

Note: The show can be joined by clicking the link to watch it online or by listening in by phone. If you'd like to ask questions at the end of the show, please dial into the show by phone at 347-637-2631. 

Thanks to our episode sponsor, GSK


We appreciate your donations to support the HealthTree Podcast for Multiple Myeloma.

DONATE

Schedule & Agenda

The panelist Jennifer Ahlstrom
Welcome
1:00 PM
Jennifer Ahlstrom

Welcome, Announcements & Introduction

The panelist Faith Davies, MBBCh, MRCP, MD, FRCPath
Interview
1:05 PM
Faith Davies, MBBCh, MRCP, MD, FRCPath

A discussion with Dr. Faith Davies about research in multiple myeloma and how we get to faster cures. 

The panelist Faith Davies, MBBCh, MRCP, MD, FRCPath
Q&A
1:50 PM
Faith Davies, MBBCh, MRCP, MD, FRCPath

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. Davies questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Faith Davies, MBBCh, MRCP, MD, FRCPath
Faith Davies, MBBCh, MRCP, MD, FRCPath

Faith Davies, MBBCh, MRCP, MD, FRCPath, is a member of the faculty of the Department of Medicine at New York University Langone Health and Director of the Clinical Myeloma Program at the Perlmutter Cancer Center. She is recognized internationally for her focus on innovative targeted molecular therapies and her expertise in the treatment of relapsed refractory disease. Her focus is on the biology and treatment of myeloma with an emphasis on potential new drugs and new genetic technologies and their applications to myeloma. Her laboratory work is aimed at identifying biologically based therapeutic targets in myeloma that are amenable to small molecule interventions and translating those laboratory findings into individualized treatment in the clinical setting. Prior to joining NYU Langone Health, Dr. Davies was Deputy Director of the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS). She also served as Professor of Medicine and Director of the Phase I Clinical Trials Program for both the Myeloma Institute and the Winthrop P. Rockefeller Cancer Institute. Dr. Davies came to UAMS in 2014 from the Institute of Cancer Research and the Royal Marsden Hospital, both in London. She earned her medical degree from the College of Medicine, University of Wales. She completed her general medical training in Cardiff and Birmingham and hematology specialty training in Leeds and London.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube